Target intelligence / Profile preview

Coagulation Factors II, IX, X (Nonactivated) (N/A)

Target
N/A
Molecular classification
Serine Protease (Zymogen)
01

Overview

Coagulation factors II (prothrombin), IX, and X are vitamin K-dependent plasma proteins essential for the blood coagulation cascade. In their nonactivated forms, these proteins circulate in the bloodstream as inactive zymogens and become activated through specific proteolytic cleavage during hemostasis. Factor II (prothrombin) is the precursor to thrombin, which converts fibrinogen into fibrin, leading to clot formation. Factor IX functions primarily in the intrinsic pathway of coagulation, while factor X is a central component of the common pathway and is activated by both intrinsic and extrinsic tenase complexes.

Other names
Prothrombin, Factor IX, Factor X (Nonactivated)Factor II, IX, X (Zymogens)Vitamin K-dependent coagulation factors (Nonactivated)
02

Mechanism of action

Indirectly targeted by anticoagulants that inhibit their activation or function. Warfarin inhibits vitamin K-dependent carboxylation, leading to production of non-functional factors. Direct Factor Xa inhibitors directly inhibit the activated form of Factor X. Heparin enhances antithrombin, which inhibits several coagulation factors including thrombin and factor Xa.

03

Biological functions

Blood coagulationHemostasisVitamin K-dependent carboxylation
04

Disease associations

Hemophilia B (Factor IX deficiency)Prothrombin deficiencyFactor X deficiencyThrombosis (indirectly, as dysregulation can lead to hypercoagulability)
05

Safety considerations

Bleeding riskThrombosis (if levels are too high or dysregulated)Drug interactions with anticoagulants
06

Interacting drugs

Warfarin

3 more in the full profile.

07

Biomarkers

Factor II levelsFactor IX levelsFactor X levelsProthrombin Time (PT)Activated Partial Thromboplastin Time (aPTT)

Beyond the preview

Go deeper on Coagulation Factors II, IX, X (Nonactivated) (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation Factors II, IX, X (Nonactivated) (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call